本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oric Pharmaceuticals Inc.

13.91
+0.23001.68%
盘后14.170.2600+1.87%19:56 EDT
成交量:125.25万
成交额:1,733.12万
市值:13.51亿
市盈率:-7.36
高:14.16
开:13.74
低:13.42
收:13.68
52周最高:14.93
52周最低:3.90
股本:9,712.30万
流通股本:6,065.91万
量比:0.52
换手率:2.06%
股息:- -
股息率:- -
每股收益(TTM):-1.8904
每股收益(LYR):-1.8335
净资产收益率:-43.82%
总资产收益率:-27.69%
市净率:4.17
市盈率(LYR):-7.59

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities